PRESCIENT THERAPEUTICS
Company Overview
Social Media Profiles
About Prescient Therapeutics
Description
Prescient Therapeutics is an ASX-listed biotechnology company dedicated to enhancing cancer patient outcomes through the development, licensing, and collaboration on universal CAR-T therapies aimed at treating a variety of cancers.
Specialties
Universal CAR-T therapies
PTX-100 for T cell lymphomas
Oncogenic Ras pathway disruption
Orphan Drug Designation
Biotechnology collaboration
Products & Services
Universal CAR-T Therapies
PTX-100 Drug Development
Cancer Treatment Collaborations
Clinical Trials for Oncology
Licensing Agreements
Contact Information
No contact information available
Competitors & Similar Companies(6)
CarTaaS
Celltrion
Adaptimmune
Gilead Sciences
Novartis
Sangamo Therapeutics
News & Media
Search Terms:
prescient therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Prescient Therapeutics
Where is Prescient Therapeutics located?
The headquarter of Prescient Therapeutics is located in South Melbourne, Victoria, Australia
What is the official website of Prescient Therapeutics?
The official website of Prescient Therapeutics is https://www.ptxtherapeutics.com
What industry does Prescient Therapeutics belong to?
Prescient Therapeutics belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Prescient Therapeutics?
Prescient Therapeutics specializes in Universal CAR-T therapies, PTX-100 for T cell lymphomas, Oncogenic Ras pathway disruption, Orphan Drug Designation, Biotechnology collaboration.
What products and services is Prescient Therapeutics likely to offer?
Prescient Therapeutics offers Universal CAR-T Therapies, PTX-100 Drug Development, Cancer Treatment Collaborations, Clinical Trials for Oncology, Licensing Agreements.
Who are the competitors of Prescient Therapeutics?
Competitors of Prescient Therapeutics are CarTaaS, Celltrion, Adaptimmune, Gilead Sciences, Novartis, Sangamo Therapeutics.
What does Prescient Therapeutics do?
Prescient Therapeutics is an ASX-listed biotechnology company dedicated to enhancing cancer patient outcomes through the development, licensing, and collaboration on universal CAR-T therapies aimed at treating a variety of cancers.